Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/04/19
End: 01/30/23
Due: 01/30/24
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 06/30/23
Due: 06/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences | NCT04043273 | Amicus Therapeutics France SAS | user2@example.com | None | 2019-04-04 | 2023-01-30 | 2024-01-30 | - | - | 2025-07-14 |
| French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat | NCT04602364 | Amicus Therapeutics France SAS | user2@example.com | None | 2020-10-15 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |